Learn more

VIVALIS

Overview
  • Total Patents
    96
About

VIVALIS has a total of 96 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ADVANCED CELL TECH INC, ASTELLAS INST OF REGENERATIVE MEDICINE and INTRADIGM CORP.

Patent filings per year

Chart showing VIVALISs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mehtali Majid 46
#2 Guehenneux Fabienne 35
#3 Pain Bertrand 23
#4 Valarche Isabelle 21
#5 Berecibar Amaya 12
#6 Guedat Philippe 12
#7 Moreau Karine 9
#8 Champion-Arnaud Patrick 9
#9 Mohamed-Arab Celine 9
#10 Batard Luc 9

Latest patents

Publication Filing date Title
WO2013000982A1 Method for screening cells
EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
WO2012095514A1 Recombinant protein production system
WO2012093174A1 1-(6-membered azo-heterocyclic)-2,5-dihydro-1h-pyrrol-2-one derivatives as anti-hepatitis c virus, the pharmaceutical composition thereof and their therapeutic use
WO2011095596A1 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
WO2011004017A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
EP2451453A1 Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
EP2101173A1 In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein
EP1995309A1 Recombinant protein production in avian EBx® cells
WO2007135133A1 Avian cell lines derived from primordial germ cells useful for the production of substances of interest
EP1985305A1 Duck embryonic derived stem cell lines for the production of viral vaccines
EP1824966A1 Human stem cell lines derived from es cells and uses for production of vaccines and recombinant proteins
EP1637885A1 Method of screening by using conformation sensitive peptides
US2006233834A1 Production of poxviruses with adherent or non adherent avian cell lines
EP1566635A1 Microwell array chip for detecting antigen-specific lymphocyte, method of detecting antigen-specific lymphocyte and method of cloning antigen-specific lymphocyte antigen receptor gene
EP1500699A1 Production of vaccinia virus with adherent or non adherent avian cell lines
FR2836924A1 AVIAN CELL LINES USEFUL FOR THE PRODUCTION OF INTEREST SUBSTANCES